A protective and broadly cross-neutralizing epitope of human papillomavirus L2

被引：183

作者：

Gambhira, Ratish ^{[1
]}

Karanam, Balasubramanyam ^{[1
]}

Jagu, Subhashini ^{[1
]}

Roberts, Jeffrey N. ^{[4
]}

Buck, Christopher B. ^{[4
]}

Bossis, Ioannis ^{[1
]}

Alphs, Hannah ^{[1
]}

Culp, Timothy ^{[5
]}

Christensen, Neil D. ^{[5
]}

Roden, Richard B. S. ^{[1
,2
,3
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA

[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA

[3] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21231 USA

[4] NCI, Cellular Oncol Lab, Bethesda, MD 20892 USA

[5] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA

来源：

JOURNAL OF VIROLOGY | 2007年 / 81卷 / 24期

关键词：

D O I：

10.1128/JVI.00936-07

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We generated a monoclonal antibody, RG-1, that binds to highly conserved L2 residues 17 to 36 and neutralizes human papillomavirus 16 (HPV16) and HPV18. Passive immunotherapy with RG-1 was protective in mice. Antiserum to the HPV16 L2 peptide comprising residues 17 to 36 (peptide 17-36) neutralized pseudoviruses HPV5, HPV6, HPV16, HPV 18, HPV31, HPV 45, HPV 52, HPV 58, bovine papillomavirus 1, and HPV11 native virions. Depletion of HPV16 L2 peptide 17-36-reactive antibodies from cross-neutralizing rabbit and human L2-specific sera abolished cross-neutralization and drastically reduced neutralization of the cognate type. This cross-neutralization of diverse HPVs associated with cervical cancer, genital warts, and epidermodysplasia verruciformis suggests the possibility of a broadly protective, peptide-based vaccine.

引用

页码：13927 / 13931

页数：5

共 22 条

[1] Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection
Bossis, L
Roden, RBS
Gambhira, R
Yang, R
Tagaya, M
Howley, PA
Meneses, PI
[J]. JOURNAL OF VIROLOGY, 2005, 79 (11) : 6723 - 6731
[2] Vaccination against papillomavirus in cattle
Campo, MS
[J]. CLINICS IN DERMATOLOGY, 1997, 15 (02) : 275 - 283
[3] VACCINATION OF CATTLE WITH THE N-TERMINUS OF L2 IS NECESSARY AND SUFFICIENT FOR PREVENTING INFECTION BY BOVINE PAPILLOMAVIRUS-4
CHANDRACHUD, LM
GRINDLAY, GJ
MCGARVIE, GM
ONEIL, BW
WAGNER, ER
JARRETT, WFH
CAMPO, MS
[J]. VIROLOGY, 1995, 211 (01) : 204 - 208
[4] THE OPEN READING FRAME L2 OF COTTONTAIL RABBIT PAPILLOMAVIRUS CONTAINS ANTIBODY-INDUCING NEUTRALIZING EPITOPES
CHRISTENSEN, ND
KREIDER, JW
KAN, NC
DIANGELO, SL
[J]. VIROLOGY, 1991, 181 (02) : 572 - 579
[5] Differential antibody responses to a distinct region of human papillomavirus minor capsid proteins
Embers, ME
Budgeon, LR
Culp, TD
Reed, CA
Pickel, MD
Christensen, ND
[J]. VACCINE, 2004, 22 (5-6) : 670 - 680
[6] Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of L2, the minor capsid protein
Embers, ME
Budgeon, LR
Pickel, M
Christensen, ND
[J]. JOURNAL OF VIROLOGY, 2002, 76 (19) : 9798 - 9805
[7] Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies
Gaukroger, JM
Chandrachud, LM
ONeil, BW
Grindlay, GJ
Knowles, G
Campo, MS
[J]. JOURNAL OF GENERAL VIROLOGY, 1996, 77 : 1577 - 1583
[8] Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6
Kawana, K
Yoshikawa, H
Taketani, Y
Yoshiike, K
Kanda, T
[J]. JOURNAL OF VIROLOGY, 1999, 73 (07) : 6188 - 6190
[9] Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteers
Kawana, K
Yasugi, T
Kanda, T
Kino, N
Oda, K
Okada, S
Kawana, Y
Nei, T
Takada, T
Toyoshima, S
Tsuchiya, A
Kondo, K
Yoshikawa, H
Tsutsumi, O
Taketani, Y
[J]. VACCINE, 2003, 21 (27-30) : 4256 - 4260
[10] Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies
Kawana, K
Kawana, Y
Yoshikawa, H
Taketani, Y
Yoshiike, K
Kanda, T
[J]. VACCINE, 2001, 19 (11-12) : 1496 - 1502

← 1 2 3 →